Case Study: US-based Life Sciences Manufacturer achieves launch turnaround and full channel visibility with IntegriChain

How a unified market access platform helped promote long-term commercial success post-launch

A US-based Life Sciences Manufacturer faced a turbulent first launch of a pediatric ADHD treatment and, as a small, resource‑strapped team with a proprietary drug delivery platform, lacked the infrastructure and market access data needed to recover. The company turned to IntegriChain and its ICyte platform to replace manual Excel processes, shore up audit‑readiness after a regulatory setback, and find a partner to guide pricing, contracting, and channel strategy.

IntegriChain implemented Government Pricing & Rebate Managed Services, channel data aggregation and refinement, inventory analytics, and gross‑to‑net forecasting via ICyte, plus state pricing transparency advisory services. The result was a consolidated, audit‑ready single source of truth that delivered instant, accurate pricing and contracting capabilities, day‑to‑day operational stability, and data‑driven decision making — including 100% visibility to downstream inventory — enabling the manufacturer to improve distribution, payer strategies, and long‑term market access.